-
Migliorini lab
Luis Castillo Cantero, PhD candidate
«Development of Bispecific Inhibitory Chimeric Antigen Receptors (iCARs) as a Novel Strategy to Avoid Neurotoxicity in αCD19 CAR T Therapies»
Foti lab
Monika Gjorgjieva Ducros, PhD
«ERMP1 in fatty liver disease and hepatocarcinogenesis»
Luis Castillo Cantero, PhD candidate
«Development of Bispecific Inhibitory Chimeric Antigen Receptors (iCARs) as a Novel Strategy to Avoid Neurotoxicity in αCD19 CAR T Therapies»
Foti lab
Monika Gjorgjieva Ducros, PhD
«ERMP1 in fatty liver disease and hepatocarcinogenesis»
Lieu
CMU
Auditoire Renold B01.2426
Rue Michel-Servet 1, Genève
Entrée
Gratuite
Fichiers joints
Contact
hani.hassan@unige.ch